Sam Brusco, Associate Editor12.15.23
Microbot Medical, developer of the Liberty endovascular robotic surgical system, began a collaboration agreement with Corewell Health.
The multi-phased objective of this partnership, the duo said, it to enable telerobotics between remote centers using Liberty. The agreement includes the right for mutual evaluation of Liberty for remote surgeries. The effort at Corewell—a not-for-profit health system with a team of over 6,000 clinicianswill be led by Ryan Madder, MD, Corewell's section chief of interventional cardiology and director of its cardiac cath lab.
“Being able to connect between remote sites, especially at rural areas, has been a passion of mine for years, and as such I’m excited about the potential this collaboration can bring to benefit many patients in the USA and across the world,” said Dr. Madder.
"We are excited for the opportunity to collaborate with Corewell Health and Dr. Ryan Madder, innovators in the field of robotics and healthcare. Working together with a health system such as Corewell, which provides care and services in 21 hospitals, 300+ outpatient locations and several post-acute facilities, to enhance the telerobotic feature of the LIBERTY System, fits well with our mission to enable accessibility to any user, anywhere across the world for any endovascular procedure,” added Harel Gadot, Microbot’s chairman, president, and CEO. "We continue to demonstrate that the interest shown by leading medical centers in our LIBERTY System is a testament to its potential impact in the endovascular interventional space.”
In October, Microbot inked a manufacturing deal with B.Y. Medimor, a provider of new product introduction (NPI) solutions and full turnkey manufacturing.
The multi-phased objective of this partnership, the duo said, it to enable telerobotics between remote centers using Liberty. The agreement includes the right for mutual evaluation of Liberty for remote surgeries. The effort at Corewell—a not-for-profit health system with a team of over 6,000 clinicianswill be led by Ryan Madder, MD, Corewell's section chief of interventional cardiology and director of its cardiac cath lab.
“Being able to connect between remote sites, especially at rural areas, has been a passion of mine for years, and as such I’m excited about the potential this collaboration can bring to benefit many patients in the USA and across the world,” said Dr. Madder.
"We are excited for the opportunity to collaborate with Corewell Health and Dr. Ryan Madder, innovators in the field of robotics and healthcare. Working together with a health system such as Corewell, which provides care and services in 21 hospitals, 300+ outpatient locations and several post-acute facilities, to enhance the telerobotic feature of the LIBERTY System, fits well with our mission to enable accessibility to any user, anywhere across the world for any endovascular procedure,” added Harel Gadot, Microbot’s chairman, president, and CEO. "We continue to demonstrate that the interest shown by leading medical centers in our LIBERTY System is a testament to its potential impact in the endovascular interventional space.”
In October, Microbot inked a manufacturing deal with B.Y. Medimor, a provider of new product introduction (NPI) solutions and full turnkey manufacturing.